Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F16%3A10324133" target="_blank" >RIV/00216208:11140/16:10324133 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/s11523-015-0386-5" target="_blank" >http://dx.doi.org/10.1007/s11523-015-0386-5</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s11523-015-0386-5" target="_blank" >10.1007/s11523-015-0386-5</a>

Result language
angličtina
Original language name
Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)
Original language description
Thorough analysis of effects of experimental therapeutic compounds acetazolamide and isothiocyanate sulforaphane on viability, proliferation, and survival in vitro as well as in vivo of urothelial bladder carcinoma cell lines has been performed.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description